July 30, 2014
UAB begins advanced drug trial for potentially fatal pregnancy complication
The University of Alabama at Birmingham has enrolled the first patient in the United States in a Phase III clinical trial to find a treatment for preeclampsia. Preeclampsia affects a relatively small number of pregnancies – 5 to 8 percent – but its prevalence is growing.
- Alternate Title Link: http://www.al.com/news/index.ssf/2014/07/post_15.html